Variant report

Variant	rs1153321
Chromosome Location	chr21:15678724-15678725
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:15669627..15671972-chr21:15676907..15679063,2	MCF-7	breast:
2	chr21:15678271..15679097-chr21:16582211..16583261,3	MCF-7	breast:
3	chr21:15677109..15679201-chr21:16581226..16583119,2	MCF-7	breast:
4	chr21:15642588..15643376-chr21:15678270..15679084,2	MCF-7	breast:
5	chr21:15678412..15679071-chr21:15688646..15689192,2	MCF-7	breast:
6	chr21:15677584..15679731-chr21:15681094..15683819,2	MCF-7	breast:
7	chr21:15676809..15681316-chr21:16435213..16438529,7	MCF-7	breast:
8	chr21:15642588..15643574-chr21:15678270..15679033,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000180530	Chromatin interaction

Extended variants
information (count: 28 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:22)

rs_ID	r²[population]
rs1012999	1.00[CEU][hapmap];0.84[CHB][hapmap];0.95[JPT][hapmap];0.84[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs1153303	1.00[CEU][hapmap];0.85[CHB][hapmap];0.95[JPT][hapmap];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs1153307	1.00[CEU][hapmap];0.90[CHB][hapmap];0.95[JPT][hapmap];0.85[AMR][1000 genomes];0.90[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs1153316	1.00[CHB][hapmap];1.00[JPT][hapmap];0.93[ASN][1000 genomes]
rs1153317	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs1153323	1.00[CHB][hapmap];0.95[JPT][hapmap];0.97[ASN][1000 genomes]
rs1153324	1.00[CHB][hapmap];0.90[JPT][hapmap];0.97[ASN][1000 genomes]
rs1153325	0.97[ASN][1000 genomes]
rs1153327	0.97[ASN][1000 genomes]
rs1153328	0.86[CHB][hapmap];0.91[JPT][hapmap];0.96[ASN][1000 genomes]
rs1153329	0.95[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes]
rs1153331	0.97[ASN][1000 genomes]
rs1153333	0.94[CHB][hapmap];0.85[JPT][hapmap];0.89[ASN][1000 genomes]
rs1297113	0.92[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs1297115	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.99[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1297123	0.85[AMR][1000 genomes];0.91[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2159938	0.81[JPT][hapmap]
rs2403770	0.80[CHB][hapmap]
rs2822556	0.90[CHB][hapmap];0.95[JPT][hapmap];0.95[ASN][1000 genomes]
rs4817081	0.86[JPT][hapmap]
rs887768	0.80[CHB][hapmap]
rs887773	1.00[CHB][hapmap];0.95[JPT][hapmap];0.97[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv869466	chr21:15482572-15683385	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
2	nsv1066930	chr21:15626232-15724630	Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases
3	nsv459095	chr21:15626660-15698808	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases
4	nsv587044	chr21:15626660-15698808	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases
5	nsv470878	chr21:15630812-15698808	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases
6	nsv1064554	chr21:15676222-15809321	Strong transcription Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:10 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:15678200-15679200	Enhancers	HUVEC	blood vessel
2	chr21:15678400-15678800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr21:15678400-15678800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr21:15678400-15678800	Enhancers	Fetal Kidney	kidney
5	chr21:15678400-15678800	Enhancers	Hela-S3	cervix
6	chr21:15678400-15679200	Enhancers	Primary hematopoietic stem cells short term culture	blood
7	chr21:15678600-15678800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr21:15678600-15678800	Enhancers	Rectal Mucosa Donor 31	rectum
9	chr21:15678600-15679000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr21:15678600-15680600	Weak transcription	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links